Application Nr Approved Date Route Status External Links
NDA021697 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Vaprisol ® Is Indicated To Raise Serum Sodium In Hospitalized Patients With Euvolemic And Hypervolemic Hyponatremia. Vaprisol ® Is A Vasopressin Receptor Antagonist Indicated To Raise Serum Sodium In Hospitalized Patients With Euvolemic And Hypervolemic Hyponatremia ( 1 ). Limitations Of Use: Vaprisol Has Not Been Shown To Be Effective For The Treatment Of The Signs And Symptoms Of Heart Failure ( 1 ). It Has Not Been Established That Raising Serum Sodium With Vaprisol Provides A Symptomatic Benefit To Patients ( 1 ). Limitations Of Use: Vaprisol Has Not Been Shown To Be Effective For The Treatment Of The Signs And Symptoms Of Heart Failure And Is Not Approved For This Indication. It Has Not Been Established That Raising Serum Sodium With Vaprisol Provides A Symptomatic Benefit To Patients.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Conivaptan Hydrochloride CONIVAPTAN HYDROCHLORIDE ZINC12503187

Comments